Acer Therapeutics Inc. changed its state of incorporation to Delaware from Texas on May 15.
The pharmaceutical company's stockholders approved the reincorporation at their May 14 annual meeting.
Acer Therapeutics said the reincorporation did not result in any material change in its board, business, assets or financial position.
